The Neglectable Impact of Delayed Graft Function on Long-term Graft Survival in Kidneys Donated After Circulatory Death rior Organ Resilience Associates With Supe

Michèle J. de Kok, MD, y Dagmara McGuinness, MBA, PhD,z Paul G. Shiels, PhD,z Dorottya K. de Vries, MD, PhD, y Joanne B. Tutein Nolthenius, BS, y Leonie G. Wijermars, MD, PhD, y Ton J. Rabelink, MD, PhD, Lars Verschuren, PhD,§ Karen S. Stevenson, MD, PhD, David B. Kingsmore, MD, Martin McBride, PhD,jj Rutger J. Ploeg, MD, PhD, Esther Bastiaannet, PhD,y Alexander F. Schaapherder, MD, PhD, y and Jan H. Lindeman, MD, PhD yY

[1]  S. Walker,et al.  Molecular Pathways Underlying Adaptive Repair of the Injured Kidney: Novel Donation After Cardiac Death and Acute Kidney Injury Platforms. , 2020, Annals of surgery.

[2]  Denny Borsboom,et al.  Quantifying resilience of humans and other animals , 2018, Proceedings of the National Academy of Sciences.

[3]  M. Christiaans,et al.  Equivalent Long-term Transplantation Outcomes for Kidneys Donated After Brain Death and Cardiac Death: Conclusions From a Nationwide Evaluation , 2018, EClinicalMedicine.

[4]  C. Cohen,et al.  BDNF: mRNA expression in urine cells of patients with chronic kidney disease and its role in kidney function , 2018, Journal of cellular and molecular medicine.

[5]  Paul A. Wilson,et al.  A molecular signature for delayed graft function , 2018, Aging cell.

[6]  Scott W. Lowe,et al.  Putting p53 in Context , 2017, Cell.

[7]  M. Rovers,et al.  Ischaemic preconditioning for the reduction of renal ischaemia reperfusion injury. , 2017, The Cochrane database of systematic reviews.

[8]  F. Sierra,et al.  Resilience in Aging Mice. , 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

[9]  V. Rotter,et al.  p53 on the crossroad between regeneration and cancer , 2016, Cell Death and Differentiation.

[10]  J. Ringers,et al.  Defective postreperfusion metabolic recovery directly associates with incident delayed graft function. , 2016, Kidney international.

[11]  J. Lindeman,et al.  Succinate Accumulation and Ischemia–Reperfusion Injury: Of Mice but Not Men, a Study in Renal Ischemia–Reperfusion , 2016, American Journal of Transplantation.

[12]  K. Klingel,et al.  Donor brain death leads to differential immune activation in solid organs but does not accelerate ischaemia–reperfusion injury , 2016, The Journal of pathology.

[13]  Yongping Wang,et al.  LDL Receptor-Related Protein 6 Modulates Ret Proto-Oncogene Signaling in Renal Development and Cystic Dysplasia. , 2016, Journal of the American Society of Nephrology : JASN.

[14]  M. Maglione,et al.  Identification of Molecular Markers of Delayed Graft Function Based on the Regulation of Biological Ageing , 2016, PloS one.

[15]  Rachel J. Johnson,et al.  Kidney donation after circulatory death (DCD): state of the art. , 2015, Kidney international.

[16]  Shao-Chun Wang.  PCNA: a silent housekeeper or a potential therapeutic target? , 2014, Trends in pharmacological sciences.

[17]  S. Kosak,et al.  α-Catenin is an inhibitor of transcription , 2014, Proceedings of the National Academy of Sciences.

[18]  Daniel R. Richards,et al.  Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013, Proceedings of the National Academy of Sciences.

[19]  Hsin-Jung Li,et al.  SOX1 functions as a tumor suppressor by antagonizing the WNT/β‐catenin signaling pathway in hepatocellular carcinoma , 2012, Hepatology.

[20]  Michael D. Schneider,et al.  BRCA1 is an essential regulator of heart function and survival following myocardial infarction , 2011, Nature communications.

[21]  J. Ringers,et al.  Donor Brain Death Predisposes Human Kidney Grafts to a Proinflammatory Reaction after Transplantation , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  R. Stratta,et al.  Kidney transplantation from donation after cardiac death donors: lack of impact of delayed graft function on post‐transplant outcomes , 2011, Clinical transplantation.

[23]  Rachel J. Johnson,et al.  Analysis of factors that affect outcome after transplantation of kidneys donated after cardiac death in the UK: a cohort study , 2010, The Lancet.

[24]  A. Liou,et al.  Heat shock proteins: Cellular and molecular mechanisms in the central nervous system , 2010, Progress in Neurobiology.

[25]  Jie J. Zheng,et al.  Macrophage Wnt7b is critical for kidney repair and regeneration , 2010, Proceedings of the National Academy of Sciences.

[26]  R C Roovers,et al.  Crosstalk between epidermal growth factor receptor- and insulin-like growth factor-1 receptor signaling: implications for cancer therapy. , 2009, Current cancer drug targets.

[27]  A. Zorn,et al.  Interactions between SOX factors and Wnt/β‐catenin signaling in development and disease , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.

[28]  Xin Chen,et al.  Ischemic Preconditioning Attenuates Renal Ischemia-Reperfusion Injury by Inhibiting Activation of IKKβ and Inflammatory Response , 2009, American Journal of Nephrology.

[29]  H. Bouma,et al.  Signal Transduction Pathways Involved in Brain Death‐Induced Renal Injury , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[30]  John Calvin Reed,et al.  Bcl-2 family proteins and cancer , 2008, Oncogene.

[31]  Kenji Ishimoto,et al.  The Role of PPARs in Cancer , 2008, PPAR research.

[32]  S. Vainio,et al.  Wnt signaling in kidney development and disease , 2008, Organogenesis.

[33]  O. Rath,et al.  MAP kinase signalling pathways in cancer , 2007, Oncogene.

[34]  M. Hall,et al.  TOR Signaling in Growth and Metabolism , 2006, Cell.

[35]  K. Stoeber,et al.  Mcm2, Geminin, and KI67 Define Proliferative State and are Prognostic Markers in Renal Cell Carcinoma , 2005, Clinical Cancer Research.

[36]  A. Chong,et al.  Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats. , 1998, Transplantation.

[37]  R. Howard,et al.  Delayed graft function after renal transplantation. , 1998, Transplantation.

[38]  S. Kushner,et al.  Delayed function reduces renal allograft survival independent of acute rejection. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[39]  M. L. Nicholson.  Renal transplantation from non‐heart‐beating donors , 1996, The British journal of surgery.

[40]  Takaaki Kobayashi,et al.  Effect of prolonged delayed graft function on long-term graft outcome in cadaveric kidney transplantation. , 1994, Clinical transplantation.

[41]  R. Jennings,et al.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. , 1986, Circulation.

[42]  W K Vaughn,et al.  THE DETRIMENTAL EFFECTS OF DELAYED GRAFT FUNCTION IN CADAVER DONOR RENAL TRANSPLANTATION , 1984, Transplantation.

[43]  M. Little,et al.  Does Renal Repair Recapitulate Kidney Development? , 2017, Journal of the American Society of Nephrology : JASN.

[44]  L. Smirnova,et al.  Cellular resilience. , 2015, ALTEX.

[45]  J. Ringers,et al.  Interleukin-9 release from human kidney grafts and its potential protective role in renal ischemia/reperfusion injury , 2012, Inflammation Research.